NKTR-288
NKTR-288
NKTR-288 is a polyethylene glycol (PEG)-conjugate of the protein, Interferon gamma. This molecule was designed utilizing a site-specific conjugation approach to modify binding of interferon gamma with one of its substrates, and overall, to optimize the duration of interferon gamma signaling. This program has applications in a number of therapeutic indications including oncology as well as in infectious disease and others.
